|
Hazard ratio
|
95% CI
|
P-value
|
---|
Univariate analysis
| | | |
Age < 65 years old
|
0.80
|
0.67 ‒ 0.94
|
0.0072
|
Female
|
0.95
|
0.82 ‒ 1.11
|
0.5648
|
Surgery (vs. Chemotherapy)
|
0.31
|
0.24 ‒ 0.40
|
<0.0001
|
Surgery (vs. BSC)
|
0.11
|
0.08 ‒ 0.14
|
<0.0001
|
Chemotherapy (vs. BSC)
|
0.34
|
0.29 ‒ 0.40
|
<0.0001
|
Tumor Location (Head)
|
0.77
|
0.66 ‒ 0.91
|
0.0015
|
Group B (2006–2010)
|
0.81
|
0.69 ‒ 0.94
|
0.0063
|
Stage I‒III
|
0.32
|
0.25 ‒ 0.40
|
<0.0001
|
Multivariate analysis
| | | |
Age < 65 years old
|
0.94
|
0.79 ‒ 1.11
|
0.4581
|
Surgery (vs. Chemotherapy)
|
0.43
|
0.33 ‒ 0.56
|
<0.0001
|
Surgery (vs. BSC)
|
0.13
|
0.10 ‒ 0.18
|
<0.0001
|
Chemotherapy (vs. BSC)
|
0.31
|
0.26 ‒ 0.37
|
<0.0001
|
Tumor Location (Head)
|
0.83
|
0.71 ‒ 0.98
|
0.0294
|
Group B (2006–2010)
|
0.91
|
0.78 ‒ 1.06
|
0.2357
|
Stage I‒III
|
0.46
|
0.36 ‒ 0.59
|
<0.0001
|
- BSC, best supportive care.